Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ensitrelvir vs nirmatrelvir/ritonavir for COVID-19
jRCT1031230005Recruiting
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in coronavirus disease 2019 (COVID-19) comparing Ensitrelvir with Nirmatrelvir/ritonavir (2 arms). Primary endpoint: Primary: Five symptoms at day 5 or 6 after starting medications. Started Apr 2023; status: recruiting.
02
Drugs
ensitrelvirnirmatrelvir + ritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT1031230005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230005.